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Hepatitis C virus core protein, in addition to being a component of the viral capsid, has a number of regulatory functions.
Here we showed two bodies of evidence indicating that a fraction of the core protein species is a substrate of the ubiquitin
(Ub)–proteasome pathway of targeted proteolysis. First, the core protein processing the C-terminal hydrophobic region is
metabolically unstable, and incubation with a proteasome inhibitor led to a significant accumulation of the protein. Second,
an in vivo ubiquitylation assay indicates conjugation of multi-Ub chain to the unstable core protein. In contrast, a stable form
of core protein, p21, is also able to be ubiquitylated, but it links to a single or only a few Ub moiety. Therefore, processing
event(s) at the C-terminal hydrophobic domain of HCV core protein may affect the ubiquitylation pathway, particularly the
efficiency of the multi-Ub chain assembly, resulting in stable, matured core proteins. © 2001 Academic Press
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Hepatitis C virus (HCV), the most important causative
agent of posttransfusion and sporadic non-A, non-B hep-
atitis, is a positive-stranded RNA virus belonging to Fla-
viviridae (Choo et al., 1989; Kuo et al., 1989; Takeuchi et
al., 1990). Persistent infection with HCV is associated
with the development of liver cirrhosis and hepatocellu-
lar carcinoma (Saito et al., 1990). A precursor polyprotein
of ;3000 amino acids (aa) is encoded by a large open
reading frame of the genome and is further processed
into structural proteins (core, E1 and E2) and nonstruc-
tural proteins (NS2, NS3a/b, NS4A, NS4B, NS5A, and
NS5B) by cellular and viral protease(s) (Choo et al., 1991;
Grakoui et al., 1993; Hijikata et al., 1991; Shoji et al., 1999;
Takamizawa et al., 1991).
The core protein, which is derived from the N-terminus
of the viral polyprotein, forms the viral nucleocapsid
(Shimoike et al., 1999; Takeuchi et al., 1990). The amino
acid sequence of this protein is well conserved among
different HCV strains in comparison with other HCV pro-
teins. The N-terminal domain of the core protein is highly
basic, while its C-terminus is hydrophobic. Several core
proteins with different molecular sizes (16–23 kDa) have
been identified, and their subcellular localizations corre-
late with their molecular sizes (Harada et al., 1991; Liu et
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301al., 1997; Lo et al., 1994; Suzuki et al., 1995; Yasui et al.,
1998). Although the core protein is mainly detected in the
cytoplasm, it is also found in the nucleus (Liu et al., 1997;
Suzuki et al., 1995; Yasui et al., 1998). In fact, a putative
nuclear localization signal has been identified in the
N-terminal region of the protein (Suzuki et al., 1995). The
C-terminal hydrophobic region of the core protein is
considered to be a transmembrane domain that links to
endoplasmic reticulum (ER) membranes (Santolini et al.,
1994).
Nucleocapsid formation of HCV presumably involves
interactions of the core protein with viral RNA and enve-
lope protein(s) as well as the core protein’s self-interac-
tion. In fact, the interaction of HCV core protein with
specific regions of the viral genomic RNA has been
reported (Shimoike et al., 1999; Tanaka et al., 2000). It has
also been demonstrated that the core protein can not
only form homodimeric and multimeric complexes (Ma-
tsumoto et al., 1996) but also forms a hetero-dimeric
complex with the E1 protein (Lo et al., 1996). These
interactions of the core protein may be important for the
morphogenesis of HCV particles as well as for other
biological activities of structural HCV proteins. Further-
more, it has been reported that HCV core protein can
influence a variety of intracellular processes. The core
protein suppresses (Marusawa et al., 1999; Ray et al.,
1996b) or enhances (Ruggieri et al., 1997; Zhu et al., 1998)
apoptosis, suppresses the host immune response (Large
et al., 1999), and modulates transcription from several
cellular and viral promoters (reviewed in Lai and Ware,
1999; Suzuki et al., 1999). The expression of the core
0042-6822/01 $35.00
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302 SUZUKI ET AL.protein can affect lipid metabolism as well. Cells that
stably express the core protein exhibit an accumulation
of lipid droplets, and the core protein colocalizes with
human apolipoprotein AII (Barba et al., 1997; Sabile et al.,
1999). Recently, it has been demonstrated that a segment
within the core protein, which was necessary for lipid
droplet association, had a role in the maturation and
stability of the protein (Hope and McLauchlan, 2000). It
has also been shown that HCV core protein has trans-
forming potential in certain cells under some conditions
(Chang et al., 1998; Ray et al., 1996a). We have reported
that transgenic mice expressing the core protein in the
liver develop steatosis (Moriya et al., 1997) and later
epatocellular carcinoma (Moriya et al., 1998). These
results suggest that HCV core protein play pivotal roles
in the pathogenesis of hepatitis C, aside from its role as
a structural component of the viral capsid.
In the course of characterizing the HCV core protein,
we observed the generation of the C-terminally pro-
cessed core protein and its selective degradation by the
ubiquitin (Ub)–proteasome pathway. Proteolysis of the
Ub–proteasome pathway, which is the major system for
intracellular protein degradation, regulates a variety of
cell functions, including the cell cycle, transcriptional
process, and programmed developments. Results sug-
gest that the stability of the heterologous HCV core
protein species is regulated by the Ub–proteasome path-
way, which is mediated by ER-associated peptidase(s).
RESULTS
Effect of proteasome inhibitor on the expression of
HCV core protein
Ub-dependent proteolysis of a variety of eukaryotic
FIG. 1. Steady-state levels of the core protein in the presence or abse
pCAGGS (lanes 1 and 2) and pCAGC191 (lanes 3 and 4). Transfected
efore harvesting. Equivalent amounts of whole-cell lysate were separa
ntibody or anti-ezrin antibody. A band corresponding to a 17-kDa core
ndicate the HCV structural region of the polyprotein precursor open rea
roteins detected in the pCAGC191-transfected cells. Numbers above
nderline represents the epitope region for anti-core antibody used inproteins has been demonstrated using specific inhibitors
of proteasome (reviewed in Hershko and Ciechanover,1998; Varshavsky, 1997). To elucidate the role of the
Ub–proteasome pathway in the expression of HCV core
protein, we examined the effect of proteasome inhibitor
MG132 on the steady-state level of HCV core protein in
293T cells. Cells were transfected with pCAGC191, which
contains the HCV sequence of the entire core protein
region (aa 1–191) placed under the CAG promoter. Im-
munoblot analysis with anti-HCV core protein monoclo-
nal antibody revealed that cells, both in the presence and
absence of MG132, contain a predominant immunoreac-
tive species with a molecular mass of ;21 kDa (p21) and
a minor band of ;23 kDa with a slower mobility (p23)
(Fig. 1). Previous studies have suggested that p23 is a
191-aa precursor core protein and p21 is generated by
the cleavage of p23 at around aa 174 by a host signal
peptidase on the ER (Liu et al., 1997; Santolini et al.,
1994).
In addition, overnight treatment with MG132 induced
the accumulation of 17-kDa band (p17). Because the
antibody used in this study specifically recognizes the
N-terminal region (aa 1–61) of HCV core protein, this
17-kDa core protein was presumably synthesized by the
removal of the C-terminal sequence of p21. These obser-
vations suggest that the processing of HCV core protein
at its C-terminal hydrophobic region may influence the
stability of the core protein, which is controlled by a
proteasome-mediated proteolytic pathway.
Effect of processing at C-terminal region of HCV core
protein on its metabolic stability
To test the above hypothesis further, we created a
series of mutants with deleted their C-terminal regions of
the core protein and introduced the Ub/protein/reference
(UPR) technique, which produces equimolar amounts of
he proteasome inhibitor. 293T cells were transfected with empty vector
ere either treated (1) or not treated (2) with MG132 (10 mM) for 14 h
SDS–PAGE, transferred to PVDF membrane, and probed with anti-core
stabilized by MG132 is marked by asterisk. Open boxes in the top right
me. Bold lines in the middle right indicate the deduced regions of core
ld lines are the deduced residues of their N and C terminus. Dotted
udy.nce of t
cells w
ted by
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ding fratwo or more of the proteins to be monitored (Le´vy et al.,
1996). Specifically, in the present work, this method used
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303UBIQUITYLATION OF HCV CORE PROTEINlinear fusion molecules in which the Ub moiety, bearing
arginine instead of wild-type lysine at position 48, was
located between the protein of interest (HCV core pro-
tein) and a reference protein, dihydrofolate reductase
(DHFR) tagged with hemagglutinin (HA). Each fusion was
designed to be cleaved, co-translationally or nearly so,
either by Ub-specific processing proteases (UBPs) or Ub
C-terminal hydrolases after the last residue of Ub. Thus,
the fusion molecules yielded equimolar amounts of sep-
arate polypeptides. Consequently, equimolar amounts of
the reference protein, metabolically stable DHFR–HA–Ub
and several forms of the core protein were produced.
Figure 2A shows the UPR-based constructs tested;
pUPRC191 encodes the entire core protein, and
pUPRC152, C123, and C111 encode serial deletions of
the core protein that remove either a part of the C-
terminal hydrophobic region (pUPRC152) or all of the
hydrophobic region (pUPRC123 and C111). These fusion
proteins were expressed in 293T cells through transfec-
tion and then analyzed by Western blotting using anti-
core antibody and anti-HA antibody. The anti-HA anti-
body was used to detect the reference protein (Fig. 2B).
In cells transfected with pUPRC191, the p17 form of the
core protein was detectable in the presence of MG132 in
addition to predominant species, p21, which was not
affected by treatment with the inhibitor. In contrast, the
steady-state level of core protein produced from
pUPRC152, which is termed “C152” in this study, had
decreased compared to the amount of the p21 expressed
by pUPRC191. The level of C152, whose molecular size is
identical or close to p17, increased in the MG132-treated
cells, although the treatment did not change the level of
reference protein DHFR–HA–Ub in the transfectants.
Moreover, we observed little amount of core proteins in
cells that expressed by either pUPRC123 or pUPRC111;
these core proteins are termed C123 and C111, respec-
tively. Since the reference protein was readily detected in
the same lysates, this result indicates that deletions in
the constructs did not alter the level of RNA transcripts or
translational efficiency of pUPRC123 and pUPRC111.
Steady-state levels of C123 and C111 were markedly
higher in cells treated with MG132. To test the effect of
N-terminal deletions on stability of the core protein, we
constructed a series of deletion mutants and expressed
in 293T cells. Immunoblot analysis showed no apparent
decrease in the level of N-terminally deleted core pro-
teins at 23, 37, 57, 71 or 91 aa (data not shown). These
findings strongly suggest that the metabolic instability of
the core proteins processed at the C-terminal hydropho-
bic region is responsible for their decreased steady-
state levels of core proteins.
To further investigate whether the decreased steady-
state level of the core protein was caused by shortening
its half-life and to assess the effect of the proteasome
inhibitor on the fate of the newly synthesized core pro-
tein, we performed pulse–chase analyses (Fig. 3). Cells
s
ptransfected with the UPR constructs were incubated with
or without MG132, labeled with [35S]methionine-cysteine,
hen chased for lengths of time indicated in the absence
r continued presence of the inhibitor. In cells trans-
ected with pUPRC111 without MG132 treatment, C111
as rapidly degraded; the half-life of the protein ap-
eared to be ,30 min (.50% of C111 was destroyed
uring the 30-min pulse) and the protein was hardly
etected after a 3-h chase (Fig. 3A). This degradation
as inhibited by the proteasome inhibitor, and the accu-
ulation of C111 in the nucleus was observed (data not
FIG. 2. Expression of HCV core proteins in 293T cells using the UPR
technique. (A) The fusion constructs used in the UPR technique. Hy-
drophobicity profile of the core protein of clone NIHJ1 is shown on the
top. Open boxes indicate the presence of the DHFR sequence, which
is extended at the C-terminus by a sequence containing the HA
epitope, represented by hatched boxes. The UbR48 moieties bearing the
ys–Arg substitution at position 48 are represented by open ellipses.
old lines indicate the regions of each core protein expressed. The
ositions of the amino acid residues of core protein are indicated
bove the bold lines. The arrow indicates the site of in vivo cleavage by
BPs or Ub C-terminal hydrolases. Genes were subcloned under the
ontrol of the CAG promoter. (B) Steady-state levels of core proteins in
he presence or absence of the proteasome inhibitor. 293T cells were
ransfected with pUPRC191 (lanes 1 and 2), pUPRC152 (lanes 3 and 4),
UPRC123 (lanes 5 and 6), pUPRC111 (lanes 7 and 8), and empty vector
lanes 9 and 10). Transfected cells were treated (1) or not treated (2)
ith MG132 (10 mM) for 14 h before harvesting. Western blot analysis
was performed using either anti-core antibody or anti-HA antibody. The
bands of core protein and DHFR-HA-Ub (reference protein) are indi-
cated on the left.hown). Similar results were also obtained from the
ulse–chase assay in the case of C123 with or without
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304 SUZUKI ET AL.inhibitor treatment (data not shown). As shown in Fig. 3B,
C152 expressed from pUPRC152 was moderately short-
lived, and the degradation of C152 was markedly inhib-
ited by adding the inhibitor; this is consistent with the
data in Fig. 2B. Thus, these results demonstrate that the
FIG. 3. Pulse–chase analysis of the core protein with or without the
proteasome inhibitor. Cells transfected with the UPR-based core con-
structs, pUPRC111 (A) and pUPRC152 (B), were untreated (2) or pre-
treated (1) with MG132 (10 mM) for 1 h, pulse-labeled with [35S]methi-
nine-cysteine for 30 min, then chased for the indicated times in the
bsence or continued presence of MG132. At each time point, cell
ysates were immunoprecipitated with both anti-core and anti-HA an-
ibody. The reference protein DHFR-HA-Ub and core proteins C111 and
152 are indicated on the left. Major non-specific bands are marked by
sterisks.
FIG. 4. Detection of ubiquitylated forms of the core proteins. 293T c
or without (2) pMT107 as indicated. All transfected cells were treated
His6-tagged proteins were purified from the extracts by Ni
21 chelatio
ntibody (top). Core proteins conjugated to His6-Ub are denoted as Hconjugated to endogenous Ub are indicated as asterisks. Whole lysates of tran
blotting using anti-core antibody (bottom). Core proteins, C152 (lanes 1 and 2turnover of HCV core protein in the form cleaved at its
C-terminal hydrophobic region increased, and this turn-
over is involved in the proteasome activity.
Ubiquitylation of HCV core proteins
The above results led us to examine whether the Ub
moiety could be conjugated to the core proteins either in
long- or short-lived forms since the main mechanism for
the targeted protein degradation by proteasome involves
covalent modification by the attachment of multiUb,
which labels target proteins for degradation. To test this
issue, the core protein constructs were transfected into
cells along with pMT107, which encodes multimers of the
Ub moiety, each of which is tagged with a stretch of six
histidine residues (His6). After cleavage of the multimers
f the Ub by UBPs, His6-tagged Ub can be used in the
intracellular conjugating system. Figure 4 shows the re-
sults of Western blotting probed with anti-core antibody
of cell lysates either with purification by Ni21 chelation
hromatography (top) or without purification (bottom). To
haracterize the ubiquitylation of the short-lived core
rotein, pCAGC152 was cotransfected with pMT107 in
he presence of MG132, which was used to maximize the
evel of Ub-conjugated intermediates by blocking the
roteasome pathway. A group of bands of the molecular
asses expected for His6–Ub-conjugated C152 was
clearly visualized in the sample from the cotransfectant
but was not visualized in cells transfected with
pCAGC152 alone. In contrast, a band of ;30 kDa was
observed upon cotransfection of pCAGC191, which ex-
presses core protein p21, with pMT107. This demon-
strated the presence of p21 conjugated with one His6-
tagged Ub molecule. This band was not detected in cells
that were transfected with pCAGC191 alone. In all four
re transfected with pCAGC152, pCAGC191, and empty vector with (1)
G132 (10 mM) for 14 h, then were extracted at 48 h posttransfection.
matography, and were analyzed by Western blotting using anti-core
core (lane 1) and open triangle (lane 3). Core proteins that possiblyells we
with M
n chro
is-Ub-sfected cells before Ni–NTA purification were also analyzed by Western
) and p21 (lanes 3 and 4), are denoted as arrowheads.
305UBIQUITYLATION OF HCV CORE PROTEINsamples where core proteins were expressed, we ob-
served faint bands, which migrated ;8 kDa more slowly
than each core protein band, as shown by asterisks.
These slower bands most likely represent endogenous,
untagged Ub conjugates of the core proteins that may
bind nonspecifically to the Ni–NTA resin.
Taken together, these results strongly suggest that
HCV core protein processed at its C-terminal hydropho-
bic region is multi-ubiquitylated in cells and degraded by
proteasome through the Ub-linked pathway. A fraction of
the core protein that contains the hydrophobic region,
such as p21, is also ubiquitylated, but it appears to be
assembled with monoUb or only a few Ubs. Therefore,
these Ub conjugates cannot be recognized and de-
graded by proteasome.
DISCUSSION
Intracellular protein degradation is an important mech-
anism for the modulation of certain proteins and the
elimination of damaged proteins. The Ub–proteasome
pathway is the major machinery for selective protein
degradation in eukaryotic cells and is now emerging as
a crucial mechanism in cellular regulation (reviewed in
Hershko and Ciechanover, 1998; Varshavsky, 1997). Mul-
tiple molecules of Ub, a 76-amino-acid protein, attach to
the target protein making a multi-ubiquitylated substrate.
The substrate is recognized and rapidly degraded by the
26S proteasome, an ATP-dependent multi-catalytic pro-
tease complex. The linkage between Ub and the target
protein and the Ub chain elongation are performed by
the concerted action of three different enzymes, Ub-
activating (E1), Ub-conjugating (E2), and Ub-protein li-
gase (E3) enzymes. Proteolysis by the Ub system regu-
lates a variety of cell functions, including cell cycles,
various signal-transduction pathways, and embryogene-
sis. The Ub-proteasome pathway degrades not only cy-
toplasmic and nuclear proteins but also ER-retained pro-
teins after dislocating to the cytosol. The pathway, there-
fore, functions as a quality control for the ER by
degrading abnormal, misfolded, or unassembled pro-
teins.
The core protein of HCV is located at the N terminus of
the precursor polyprotein and not only is a component of
the viral capsid but also possesses a number of regula-
tory functions. These functions include regulation of cell
proliferation, apoptosis, and lipid metabolism (reviewed
in Lai and Ware, 1999; Suzuki et al., 1999). The data
presented here provide evidence that the Ub–protea-
some pathway participates in the degradation of the
short-lived HCV core protein. The data also suggest a
mechanism by which the processing at the C-terminal
hydrophobic regions of the proteins, at least in part,
regulate the proteolysis machinery for the core protein.We report the following two significant observations.
First, the core protein processed at its C-terminal hydro-phobic region, presumably by signal peptidase, is unsta-
ble in vivo. Pulse–chase assays and experiments utiliz-
ing the UPR technique indicated that the decreased
protein levels in cells result from increasing protein turn-
over and not from mRNA instability or inefficiency in
translation. A specific inhibitor of the 20S proteasome
stabilizes the short-lived form of the core protein, impli-
cating the proteasome machinery in its degradation. By
contrast, the predominant form of core protein, p21, is
long-lived and not affected by treatment with the protea-
some inhibitor. While our data indicated here have been
obtained from transfection experiments using 293T cells,
human embryonic kidney cells, we found that C152 was
similarly unstable in human hepatoma cells FLC4 (Aoki
et al., 1998) (data not shown).
Second, core proteins in both long- and short-lived
forms are ubiquitylated in cells. In Western blot analyses
using anti-core antibody after isolation by metal chela-
tion chromatography, we detected C-terminally pro-
cessed (short-lived) core protein conjugated with multi-
ple epitope-tagged Ub from lysates of cells that coex-
pressed with His6-tagged Ub. A fraction of the long-lived
core protein was also ubiquitylated, but it was a poorly
assembled multiUb chain. MonoUb-core conjugate was
observed only in Western blotting in cells expressed
together with His6-tagged Ub (Fig. 4).
The homopolymeric multi-Ub chain, in which multiple
Ubs are linked through Lys48–Gly76 isopeptide bonds, is
a signal to the proteasome for targeting substrates. It has
been reported that a substrate-conjugating chain of 8–12
Ubs is degraded 10 times faster than a substrate bearing
mono-Ub (Chau et al., 1989). Such length-dependent dif-
ferential signal may be reflected in the properties of
multiUb chain-binding proteins such as S5a, MBP1, or
MCB1, of the 19S regulatory complex of 26S proteasome
(Deveraux et al., 1994; van Nocker et al., 1996). Recently,
Thrower et al. (2000) indicated that tetra-Ub is the mini-
mal signal for efficient proteasomal targeting through
studies that employed structurally defined multi-ubiqui-
tylated substrates. The same scenario is suggested for
HCV core destabilization. The difference in the stability of
the HCV core protein species is dependent upon the Ub
chain assembly (i.e., the number of Ubs conjugated) on
the core proteins.
The data presented in this work lead to the following
model for the ubiquitylation and degradation of the core
protein (Fig. 5). The first step is the processing of the
precursor polyprotein by cellular and viral proteases. The
host signalase on the ER catalyzes cleavages within the
structural region, including core/E1 (Hijikata et al., 1991;
Santolini et al., 1994). Another membrane-associated en-
zyme proposed by Hu¨ssy et al. (1996) as a signal peptide
peptidase also may be involved in the biogenesis of the
heterologous species of the core protein, through which
the C-terminal hydrophobic region is further processed.
The data regarding the expression of core protein in the
r306 SUZUKI ET AL.presence or absence of the proteasome inhibitor sug-
gest that processed and short-lived core protein species
with molecular mass of 17 kDa are possibly generated in
the course of precursor processing. In fact, a similar
molecular mass of HCV core, which presumably results
from cleavage at around aa 151, has been previously
reported together with two major core proteins, p21 and
p23 (Lo et al., 1994).
The C-terminal cleaved form of p17 is multi-ubiquity-
lated, while p21 appears to be linked to only one or a few
Ub moieties. This finding raises the question of why
multiUb chain(s) assembled only on the core protein that
was processed with C-terminal hydrophobic region. We
speculate that such diversity in the Ub chain assembly
could be achieved through variations in the conformation
status of core proteins after processing from the precur-
sor polyprotein.
Although no three-dimensional structural data are
available yet for HCV core protein, studies using a series
of monoclonal antibodies directed against HCV core
have suggested that the core proteins located in the
cytoplasm and nucleus have different higher-order struc-
tures (Yasui et al., 1998). Conformation of the C-terminal-
processed version of core protein could make the multi-
ubiquitylation machinery vulnerable to the core protein.
The long-lived form of the core protein is apparently
recognized by the Ub-conjugating system, but the ubiq-
uitylation machinery in this case stops after only one or
a few cycles. This phenomenon could be caused by
steric constraints. A distinct conformation of the core
protein could interfere with the elongation of the Ub
chain. Recently, a novel ubiquitylation factor named E4
FIG. 5. A model for the processing of HCV precursor and the deg-
adation of the core protein by the Ub–proteasome pathway.has been identified in yeast. In conjunction with E1, E2,
and E3, this additional factor binds to Ub moieties ofUb-substrate conjugates and facilitates multi-Ub chain
assembly (Koegl et al., 1999). Thus, it is possible that a
similar factor might interact preferentially with the con-
jugates of Ub with C-terminal-processed core protein,
then display its Ub chain elongation activity. Also, we
cannot exclude the possibility that differences in subcel-
lular localization of core proteins (p21 in cytoplasm vs
p17 in nucleus, data not shown) influence the ubiquity-
lation pathway, in which distinct E2s/E3s may play a role
in ubiquitylation in the cytoplasm and nucleus.
Ultimately, multi-ubiquitylated core protein is recog-
nized and degraded by proteasome. The biological sig-
nificance of the Ub–proteasome-mediated degradation
of HCV core protein is not yet understood. Additional
studies are needed to determine how multi-ubiquitylated
core protein(s) such as p17 play any functional role
during HCV infection. However, existence of different
outcomes for ubiquitylated core proteins leads to some
important considerations.
Targeted protein degradation is increasingly under-
stood to be an important general mechanism by which
cells regulate the levels of specific proteins and thereby
regulate their functions. For example, transcriptional al-
terations and cell cycle progression are often achieved
through a coordinated degradation of regulatory pro-
teins. HCV core protein is now known as a regulatory
factor, which modulates some signaling pathways and
expression levels directed by a variety of promoters
(reviewed in Lai and Ware, 1999; Suzuki et al., 1999). One
could argue that the elimination of core protein by the
Ub–proteasome pathway leads to a decrease in the
perturbation of intracellular processes by the core pro-
tein. This destabilizing machinery may contribute to the
down-regulation of liver damage or to the viral pathogen-
esis that occurs during HCV infection.
Another pivotal role of proteasome is its involvement
in cellular antigen presentation. Viral antigens degraded
by proteasome are presented by the major histocompat-
ibility complex class I molecules synthesized within the
virus-infected cells (Michalek et al., 1993). Thus, the
peptide epitopes are recognized by CD81 cytotoxic T
lymphocytes (CTLs), conferring on these CTLs the ability
to lyse virus-infected cells. In HCV infection, a number of
CTL epitopes including peptide sequences in the core
protein were identified (Kaneko et al., 1996; Koziel et al.,
1995). However, HCV-specific CTL in the liver of chroni-
cally infected individuals do not seem to lead to effective
viral elimination. Peptide substrates from core protein for
HLA class I pathway could be generated through the
mechainsm coupled by membrane-associated pro-
teases with the Ub–proteasome pathway. In regard to the
functional role of monoubiquitylated, long-lived core pro-
tein, it is possible that the Ub-core conjugate is involved
in the assembly of virus particles or in their budding from
infected cells, as has been suggested in the case of
other viruses (Dunigan et al., 1988; Guarino et al., 1995;
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307UBIQUITYLATION OF HCV CORE PROTEINHingamp et al., 1995; Ott et al., 1998; Reilly and Guarino,
1996). For example, Ub is present inside several retrovi-
ruses, and such virus contains, in addition to free Ub, a
fraction of mature Gag protein conjugated with a single
Ub (Ott et al., 1998). It is now necessary to elucidate the
nature of the hypothetical roles of ubiquitylated core
proteins as discussed above.
In summary, we have presented evidence that pro-
cessing events at the C-terminal hydrophobic region of
the HCV core protein affect its ubiquitylation manner and
consequently regulate the stability of matured core pro-
tein by the Ub–proteasome pathway.
MATERIALS AND METHODS
Plasmid constructs
The His6-tagged Ub expression construct, pMT107
(Treier et al., 1994), was provided by Dr. D. Bohmann,
European Molecular Biology Laboratory. It contains the
promoter/enhancer region from cytomegalovirus and the
sequence encoding a multimeric precursor molecules
composed of eight Ub units with N-terminally added His6
tag.
The cDNA clones of HCV genotype 1b, NIHJ1, used in
this study were originally isolated from an HCV carrier
plasma that was infectious for both humans and chim-
panzees (Aizaki et al., 1998). cDNA fragments coding for
HCV core proteins were generated using PCR amplifica-
tion with the Expand high-fidelity PCR system (Roche
Molecular Biochemicals, Indianapolis, IN) and specific
primers. PCR introduced a translational terminal codon
at the end of the HCV coding sequences. The BglII-cut
PCR fragments were cloned into the BglII site of the
pCAGGS vector, in which the HCV core proteins were
expressed under the control of the CAG promoter (Niwa
et al., 1991).
The plasmids for the UPR technique (Le´vy et al., 1996)
ere constructed using multiple-step PCR. Plasmids
ontaining cDNAs for DHFR–HA tag-Ub–methionine/ar-
inine-b-galactosidase (Suzuki and Varshavsky, 1999)
nd cDNA clone for HCV were used as templates for
CR amplification. The BglII-cut PCR fragments were
loned into the BglII site of the pCAGGS vector. The
esulting UPR constructs expressed the fused proteins of
HFR–HA tag-Ub–HCV core proteins (Fig. 2A). All of the
CV cDNA clones derived from PCR were verified by
equencing.
ell culture and transfection
The human embryonic kidney cell line, 293T, was
aintained in Dulbecco’s modified Eagle’s medium
DMEM) supplemented with 100 units/ml of penicillin,
00 mg/ml of streptomycin, and 10% fetal bovine serum
FBS), at 37°C in a 5% CO2 incubator. Monolayers of 293T
cells were transfected with plasmid DNA in the presence
a
iof Lipofectoamine (Gibco BRL, Life Technologies, Gaith-
ersburg, MD) according to the manufacturer’s instruc-
tions. The total amount of DNA in the experiments was
kept constant by adding the respective empty vector
plasmid DNAs to the transfection mixture.
Antibodies
Anti-HCV core monoclonal antibody A1/3D1, which is
reactive with aa 1–61 of HCV core protein, was obtained
from ANOGEN (Mississauga, Canada). Monoclonal anti-
body 3C12 against ezrin and polyclonal anti-HA antibody
were obtained from SIGMA (St. Louis, MO) and Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA), respectively.
Immunoblotting
In some experiments, cells were treated with MG132
(supplied by Boston Biochem, Cambridge, MA) at 10 mM
or 14 h before harvesting. As a control for the inhibitor
xperiment, cells cultured in a medium containing an
qual concentration of dimethyl sulfoxide were used.
orty-eight hours after transfection, cells were washed
ith phosphate-buffered saline (PBS) and incubated with
NE buffer (10 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM
DTA, 1% Nonidet-P40) containing 0.5% sodium dodecyl
ulfate (SDS). Lysates were then sonicated for 10 min
nd added to the same volume of SDS sample buffer
ontaining 20% glycerol, 4.6% SDS, 125 mM Tris–HCl (pH
.8), 10% 2-mercaptoethanol, and 0.2% bromphenol blue.
he protein samples were boiled for 15 min, separated
y SDS–polyacrylamide gel electrophoresis (SDS–
AGE), and transferred to polyvinylidene difluoride
PVDF) membrane (Immobilon; Millipore, Tokyo, Japan).
fter blocking, the membranes were probed with anti-
ore antibody, anti-HA antibody, or anti-ezrin antibody.
mmunoblots were developed as described previously
Harada et al., 1991).
Pulse–chase experiments
Twenty-four hours after transfection, the cells were
washed with PBS and incubated in DMEM lacking me-
thionine and cysteine in the presence or absence of
MG132 as described above for 1 h at 37°C. The cells
were pulse-labeled with 15 mCi of [35S]methionine-cys-
teine (Tran35S-label; ICN Biomedicals, Inc., Costa Mesa,
CA) for 30 min, washed once with PBS, and chased with
DMEM containing 10% FBS in the presence or absence
of the inhibitor. At each time point, the cells were washed
with PBS, lysed with 400 ml of TNE buffer containing 0.5%
DS and Protease Inhibitor Cocktail (Roche Molecular
iochemicals), and sonicated for 10 min. After centrifu-
ation at 12,000 g for 10 min at 4°C to remove insoluble
ell debris, 400 ml of the supernatants were diluted with
600 ml of TNE buffer, incubated with anti-core antibody
nd anti-HA antibody for 4 h at 4°C with rotation, and
mmunoprecipitated by protein A–sepharose (Pharma-
w
c
l
p
a
T
(
b
u
t
N
s
s
a
G
i
S
P
S
308 SUZUKI ET AL.cia, Tokyo, Japan). After centrifugation at 12,000 g for 1
min at 4°C, the pellets were washed four times with TNE
buffer containing 0.1% SDS. Immunoprecipitates were
resuspended in the SDS sample buffer and boiled for 5
min. Samples were separated by SDS–PAGE and ana-
lyzed by autoradiography.
Protein purification
Thirty-four hours after transfection with the core and
His6-tagged Ub constructs, the cultures were treated
ith 10 mM MG132 for 14 h before being harvested. The
ells were then washed with PBS and suspended in a
ysis buffer (8 M urea, 0.1 M NaH2PO4, 0.01 M Tris–HCl,
H 8.0). The lysate was stirred for 60 min and centrifuged
t 12,000 g for 30 min to remove insoluble cell debris.
he supernatant was applied to the Ni–NTA column
QIAGEN, Hilden, Germany) equilibrated with the lysis
uffer. The column was successively washed with 8 M
rea, 0.1 M NaH2PO4, 0.01 M Tris–HCl (pH 6.3). His6-
agged proteins were eluted with 8 M urea, 0.1 M
aH2PO4, 0.01 M Tris–HCl (pH 4.5). The eluate was
trichloroacetic acid-precipitated for further immunoblot-
ting analysis.
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